AGP Limited (PSX:AGP)

Market Cap	53.55B
Revenue (ttm)	27.73B
Net Income (ttm)	3.69B
Shares Out	280.00M
EPS (ttm)	13.19
PE Ratio	14.50
Forward PE	11.46
Dividend	4.00 (2.13%)
Ex-Dividend Date	Sep 2, 2025

Volume	700,928
Average Volume	268,102
Open	188.00
Previous Close	187.70
Day's Range	187.00 - 196.00
52-Week Range	142.00 - 220.02
Beta	0.28
RSI	56.40
Earnings Date	Feb 26, 2026

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.